Checking thyroid function in adults on hemodialysis at Sohag University Hospital
Assessment of Thyroid Dysfunction in Patients Undergoing Haemodialysis at Sohag University Hospital
This project tests whether routine thyroid blood tests find thyroid problems in adults who have been on regular hemodialysis for at least three months.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1 (estimated) |
| Ages | 13 Years to 80 Years |
| Sex | All |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Trial ID | NCT07022236 on ClinicalTrials.gov |
What this trial studies
This observational study will measure thyroid function (typical thyroid profile tests such as TSH, free T4, and free T3) in adults with end-stage renal disease receiving regular hemodialysis at Sohag University Hospital. Patients with prior thyroid disease, recent thyroid treatment, acute kidney injury, pregnancy, or medications known to affect thyroid tests are excluded. Results will be analyzed for the prevalence of thyroid dysfunction and correlations with clinical factors such as dialysis duration and comorbidities. The study involves blood sampling during routine clinic visits and does not introduce experimental treatments.
Who should consider this trial
Good fit: Adults aged 18 or older with end-stage renal disease who have been on regular hemodialysis for at least three months and who do not have a prior history of thyroid disease or recent thyroid treatment are ideal candidates.
Not a fit: Patients with known thyroid disorders, recent thyroid treatment, acute kidney injury, pregnancy or lactation, or who are taking medications that interfere with thyroid tests are unlikely to benefit from this study.
Why it matters
Potential benefit: If successful, the findings could support more routine thyroid screening for people on long-term hemodialysis, enabling earlier detection and management of thyroid-related complications.
How similar studies have performed: Prior observational studies have repeatedly shown a high prevalence of thyroid dysfunction among dialysis patients, supporting routine screening, though interventional benefits from screening are less well established.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 years and older. * Patients diagnosed with end-stage renal disease (ESRD) on regular hemodialysis for at least 3 months. Exclusion Criteria: * Known Thyroid Disorders: Patients with a history of thyroid disease (e.g., hypothyroidism, hyperthyroidism) prior to starting dialysis. * Recent Thyroid Treatment: Patients who have received treatment for thyroid dysfunction (e.g., thyroid hormone replacement, antithyroid medications) within the last six months. * Patients with acute kidney injury (AKI) or those who are not on regular dialysis. * Pregnant or lactating women. * Patients with systemic illnesses or medications that could interfere with thyroid function tests (e.g., corticosteroids, lithium).
Where this trial is running
Sohag
- Hospital — Sohag, Egypt (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.